Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma.
Saved in:
| Title: | Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma. |
|---|---|
| Authors: | Rimassa L; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milan), Italy.; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano (Milan), Italy., Kelley RK; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA., Meyer T; Royal Free Hospital and UCL Cancer Institute, London, United Kingdom., Ryoo BY; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Merle P; Groupement Hospitalier Lyon Nord, Lyon, France., Park JW; National Cancer Center, Goyang, Republic of Korea., Blanc JF; Hôpital Haut-Lévêque, CHU Bordeaux, Bordeaux, France., Lim HY; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Tran A; Université Côte d'Azur, Nice, France.; CHU de Nice, Digestive Center, Nice, France.; INSERM, U1065, C3M, Team 8, Nice, France., Chan YW; Fios Genomics Ltd, Edinburgh, United Kingdom., McAdam P; Fios Genomics Ltd, Edinburgh, United Kingdom., Wang E; Exelixis, Inc., Alameda, California, USA., Cheng AL; National Taiwan University College of Medicine, Taipei, Taiwan., El-Khoueiry AB; USC Norris Comprehensive Cancer Center, Los Angeles, California, USA., Abou-Alfa GK; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Weill Medical College at Cornell University, New York, New York, USA. |
| Source: | Liver cancer [Liver Cancer] 2021 Dec 03; Vol. 11 (1), pp. 38-47. Date of Electronic Publication: 2021 Dec 03 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: S. Karger Country of Publication: Switzerland NLM ID: 101597993 Publication Model: eCollection Cited Medium: Print ISSN: 2235-1795 (Print) Linking ISSN: 16645553 NLM ISO Abbreviation: Liver Cancer Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2235-1795 |
|---|---|
| DOI: | 10.1159/000519867 |
